✦ LIBER ✦

The myosin ATPase inhibitor, 2,3-butanedione 2-monoxime, prevents protein secretion by the basidiomyceteCoprinopsis cinerea

✍ Scribed by Kohsuke Hashimoto; Etsuo Yokota; Teruo Shimmen; Makoto Yoshida

Book ID: 106364991
Publisher: Springer Netherlands
Year: 2010
Tongue: English
Weight: 264 KB
Volume: 33
Category: Article
ISSN: 0141-5492
DOI: 10.1007/s10529-010-0497-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The myosin ATPase inhibitor 2,3-butanedi

The myosin ATPase inhibitor 2,3-butanedione-2-monoxime disorganizes microtubules as well as F-actin inSaccharomyces cerevisiae

✍ K. Chon; H.-S. Hwang; J.-H. Lee; K. Song 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 547 KB

The myosin ATPase inhibitor 2,3-butanedi

The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast,Schizosaccharomyces pombe

✍ May, Karen M. ;Wheatley, Sally P. ;Amin, Vasanti ;Hyams, Jeremy S. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

The growth of fission yeast cultures was reversibly inhibited by exposure to the myosin-ATPase inhibitor 2,3-butanedione-2-monoxime (BDM). Wild-type cells treated with 20 mM BDM for approximately two generation times were smaller than untreated controls and had a septation index approximately twice

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTA

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTANEDIONE MONOXIME (BDM) ON CELL SHAPE, LOCOMOTION AND FLUID PINOCYTOSIS IN HUMAN POLYMORPHONUCLEAR LEUCOCYTES

✍ N. Urwyler; P. Eggli; H.U. Keller 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 696 KB

## Abstract We investigated the role of myosin in polymorphonuclear leucocyte (PMN) shape changes, locomotion, and fluid pinocytosis using the myosin inhibitor 2,3 butanedione monoxime (BDM). Treatment of resting spherical PMNs with BDM produced spheroid cells showing small continuous shape changes

A C-terminal domain, which prevents secr

A C-terminal domain, which prevents secretion of the neuroendocrine protein 7B2 in Saccharomyces cerevisiae, inhibits Kex2 yet is processed by the Yap3 protease

✍ Bhabatosh Chaudhuri; Christine Stephan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 795 KB

The human complement receptor type 2 (CR

The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity

✍ Michael Holers; Nirmal Banda; Gaurav Mehta; Masha Fridkis-Hareli; Eran Or; Micha 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB